# Research Study on Whether Semaglutide Works in People With Non-alcoholic Steatohepatitis (NASH)

> **NCT04822181** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **Novo Nordisk A/S** · enrollment: 1205 (actual)

## Conditions studied

- Non-alcoholic Steatohepatitis

## Interventions

- **DRUG:** Semaglutide
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04822181
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-04-01
- **Primary completion:** 2029-04-25
- **Final completion:** 2029-04-25
- **Target enrollment:** 1205 (ACTUAL)
- **Last updated:** 2026-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04822181

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04822181, "Research Study on Whether Semaglutide Works in People With Non-alcoholic Steatohepatitis (NASH)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04822181. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*